MSB 2.67% 96.0¢ mesoblast limited

Growing doubt on COVID-19 Application, page-2617

  1. 4,959 Posts.
    lightbulb Created with Sketch. 782
    What is a Little bit hard for me to comprehend is how the cultists are blindly convinced that this company will be successful. The company has stated that its focus is the COVID-19 application. But, msb’s big pharma partner looked at the data and ended the partnership

    Now, ordinarily, this would ring alarm bells. I mean, Covid is the biggest health emergency in the world for 100 years. One would think a miracle cure would be the most valuable asset a drug company could ever hope to be a part of?

    But nope, Novartis said no way. And msb said the Covid application is still a focus.

    Then, we look at the FDA. Not only, again remembering the biggest health emergency for a century, did the FDA say no emergency use, they said piss off and do more trials (ie if you to, because we think it’s never going to work). Oh, I before you fix up your quality control problems which have been ongoing and still unresolved.

    For not the first time, this application has no prospect of approval. Very like, stems just don’t work as advertised.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
96.0¢
Change
0.025(2.67%)
Mkt cap ! $1.096B
Open High Low Value Volume
95.0¢ 96.5¢ 94.0¢ $1.231M 1.291M

Buyers (Bids)

No. Vol. Price($)
4 94461 95.0¢
 

Sellers (Offers)

Price($) Vol. No.
96.0¢ 61151 6
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.